Profile

Dr. Aleksei Tikhonov, MSc, PhD

Gustave Roussy

Contact Details

Bio

With more than 5 years of experience in biomarker discovery, assay development, and laboratory medicine, I have successfully implemented bioanalytical and translational strategies to advance clinical progress. My proven track record in managing R&D projects demonstrates my dedication to delivering high-quality, timely results and ensuring exceptional patient care. I am committed to fostering innovation through collaborative leadership, building strategic partnerships, and advocating for Diversity, Equity, and Inclusion (DEI) in healthcare. Major Impacts and Accomplishments: - Managed and led translational research projects, resulting in 2 patents and 10 publications. - Developed and validated fit-for-purpose ligand-binding assays (LBA) for biomarker quantification, ensuring robust bioanalytical strategies. - Designed and wrote 5+ phase I-III immuno-oncology clinical trials, including NCT04739566 and NCT04737740. - Launched 20+ innovative advanced chemicals globally at Lumiprobe, enhancing brand awareness and customer engagement. - Supervised a team of 4 writers and designers in a biotechnology company and mentored students and technicians in academia. - Held leadership positions in scientific associations (ADLM, EFLM, SITC) and established effective stakeholder relationships.

Volunteer Bio  

With more than 5 years of experience in biomarker discovery, assay development, and laboratory medicine, I have successfully implemented bioanalytical and translational strategies to advance clinical progress. My proven track record in managing R&D projects demonstrates my dedication to delivering high-quality, timely results and ensuring exceptional patient care.
I am committed to fostering innovation through collaborative leadership, building strategic partnerships, and advocating for Diversity, Equity, and Inclusion (DEI) in healthcare.

Major Impacts and Accomplishments:
- Managed and led translational research projects, resulting in 2 patents and 10 publications.
- Developed and validated fit-for-purpose ligand-binding assays (LBA) for biomarker quantification, ensuring robust bioanalytical strategies.
- Designed and wrote 5+ phase I-III immuno-oncology clinical trials, including NCT04739566 and NCT04737740.
- Launched 20+ innovative advanced chemicals globally at Lumiprobe, enhancing brand awareness and customer engagement.
- Supervised a team of 4 writers and designers in a biotechnology company and mentored students and technicians in academia.
- Held leadership positions in scientific associations (ADLM, EFLM, SITC) and established effective stakeholder relationships.